These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1647337)

  • 1. The influence of pyridostigmine administration on human neuromuscular functions--studies in healthy human subjects.
    Glikson M; Achiron A; Ram Z; Ayalon A; Karni A; Sarova-Pinchas I; Glovinski J; Revah M
    Fundam Appl Toxicol; 1991 Feb; 16(2):288-98. PubMed ID: 1647337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2-4 (SPACE trial).
    Stam M; Wadman RI; Wijngaarde CA; Bartels B; Asselman FL; Otto LAM; Goedee HS; Habets LE; de Groot JF; Schoenmakers MAGC; Cuppen I; van den Berg LH; van der Pol WL
    BMJ Open; 2018 Jul; 8(7):e019932. PubMed ID: 30061431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of oral pyridostigmine bromide nerve agent prophylaxis on return of twitch height in persons receiving succinylcholine.
    Pellegrini JE; Baker AB; Fontenot DJ; Cardenas AF
    Mil Med; 2000 Apr; 165(4):252-5. PubMed ID: 10802993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular function and plasma drug levels in pyridostigmine treatment of myasthenia gravis.
    Breyer-Pfaff U; Schmezer A; Maier U; Brinkmann A; Schumm F
    J Neurol Neurosurg Psychiatry; 1990 Jun; 53(6):502-6. PubMed ID: 2166138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular toxicity of pyridostigmine bromide in the diaphragm, extensor digitorum longus, and soleus muscles of the rat.
    Hudson CS; Foster RE; Kahng MW
    Fundam Appl Toxicol; 1985 Dec; 5(6 Pt 2):S260-9. PubMed ID: 4092893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyridostigmine toxicity. Electrophysiological study.
    Park KH; Kim DE; Arnold TW; Oh SJ; Bradley R
    Electromyogr Clin Neurophysiol; 1993 Sep; 33(6):323-8. PubMed ID: 8223330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pretreatment with oral pyridostigmine on subsequent activity of alcuronium in non-anaesthetized subjects.
    Turner GA; Williams JD; Baker DJ
    Br J Anaesth; 1991 Mar; 66(3):365-9. PubMed ID: 1849730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyridostigmine in postpolio syndrome: no decline in fatigue and limited functional improvement.
    Horemans HL; Nollet F; Beelen A; Drost G; Stegeman DF; Zwarts MJ; Bussmann JB; de Visser M; Lankhorst GJ
    J Neurol Neurosurg Psychiatry; 2003 Dec; 74(12):1655-61. PubMed ID: 14638885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of daily stress or repeated paraoxon exposures on subacute pyridostigmine toxicity in rats.
    Shaikh J; Karanth S; Chakraborty D; Pruett S; Pope CN
    Arch Toxicol; 2003 Oct; 77(10):576-83. PubMed ID: 14574445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of pyridostigmine on respiratory function in healthy and asthmatic volunteers.
    Ram Z; Molcho M; Danon YL; Almog S; Baniel J; Karni A; Shemer J
    Isr J Med Sci; 1991; 27(11-12):664-8. PubMed ID: 1757243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myopathic changes in diaphragm of rats fed pyridostigmine bromide subchronically.
    Bowman PD; Schuschereba ST; Johnson TW; Woo FJ; McKinney L; Wheeler CR; Frost D; Korte DW
    Fundam Appl Toxicol; 1989 Jul; 13(1):110-7. PubMed ID: 2767351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of pyridostigmine in reversing neuromuscular blockade produced by soman.
    Dirnhuber P; Green DM
    J Pharm Pharmacol; 1978 Jul; 30(7):419-25. PubMed ID: 27607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma concentration of pyridostigmine and effects in myastenia gravis.
    Chan K; Calvey TN
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):596-601. PubMed ID: 199393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pyridostigmine on ability of rats to work in the heat.
    Francesconi R; Hubbard R; Mager M
    J Appl Physiol Respir Environ Exerc Physiol; 1984 Apr; 56(4):891-5. PubMed ID: 6725066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and repeated restraint stress have little effect on pyridostigmine toxicity or brain regional cholinesterase inhibition in rats.
    Song X; Tian H; Bressler J; Pruett S; Pope C
    Toxicol Sci; 2002 Sep; 69(1):157-64. PubMed ID: 12215670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute behavioral toxicity of pyridostigmine or soman in primates.
    Blick DW; Murphy MR; Brown GC; Yochmowitz MG; Fanton JW; Hartgraves SL
    Toxicol Appl Pharmacol; 1994 Jun; 126(2):311-8. PubMed ID: 8209384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromuscular blocking action of suxamethonium after antagonism of vecuronium by edrophonium, pyridostigmine or neostigmine.
    Fleming NW; Macres S; Antognini JF; Vengco J
    Br J Anaesth; 1996 Oct; 77(4):492-5. PubMed ID: 8942334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged administration of pyridostigmine impairs neuromuscular function with and without down-regulation of acetylcholine receptors.
    Richtsfeld M; Yasuhara S; Fink H; Blobner M; Martyn JA
    Anesthesiology; 2013 Aug; 119(2):412-21. PubMed ID: 23563362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of repeated doses of 30 mg pyridostigmine bromide on pilot performance in an A-4 flight simulator.
    Izraeli S; Avgar D; Almog S; Shochat I; Tochner Z; Tamir A; Ribak J
    Aviat Space Environ Med; 1990 May; 61(5):430-2. PubMed ID: 2190549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of pyridostigmine in hypertensive patients receiving beta blockers.
    Arad M; Roth A; Zelinger J; Zivner Z; Rabinowitz B; Atsmon J
    Am J Cardiol; 1992 Feb; 69(5):518-22. PubMed ID: 1346558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.